Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/2005
11/03/2005WO2005028620A3 Histone modifications as binary switches controlling gene expression
11/03/2005WO2005028517A3 SOLUBLE TGF-β TYPE III RECEPTOR FUSION PROTEINS
11/03/2005WO2005025590A3 Use of a dg280 protein product for preventing and treating metabolic disorders
11/03/2005WO2005021722A3 METHODS AND COMPOSITIONS FOR INHIBITION OF NUCLEAR FACTOR κB
11/03/2005WO2005016285A3 Compositions and methods for inhibiting slit protein and glypican interactions
11/03/2005WO2005009396A3 Methods and compositions for the treatment and prevention of staphylococcus and other bacterial infections
11/03/2005WO2004108070A3 Releasable polymeric conjugates based on aliphatic biodegradable linkers
11/03/2005WO2004084827A3 Reduction of zinc-induced neurotoxic injury by blockade of nitric oxide synthesis
11/03/2005WO2004072243A3 Macrocyclic hepatitis c serine protease inhibitors
11/03/2005WO2004072240A8 Antiplasmin cleaving enzyme
11/03/2005WO2003068168A3 Helical peptidomimetics and use b-amyloid-associated diseases
11/03/2005WO2003066000A3 Formulation comprising bioactive agents and method of using same
11/03/2005US20050246780 Phytases, nucleic acids encoding them and methods for making and using them
11/03/2005US20050246566 Process for providing submodel performance in a computer processing unit
11/03/2005US20050245731 DNA encoding tumor necrosis factor inhibitory protein and its use
11/03/2005US20050245730 Wound healing agents; anticancer agents; cardiovascular disorders; immunostimulants
11/03/2005US20050245511 Novel compounds that inhibit tryptase activity
11/03/2005US20050245476 Introducing nucleic acid encoding a protein comprising an engineered zinc finger DNA-binding domain
11/03/2005US20050245473 Proliferation- and differentiation-modulating agents and uses therefor
11/03/2005US20050245472 Engineered rnai adenovirus silencing expression (erase) of dna reair proteins
11/03/2005US20050245471 Combination products for use in antitumoral treatment
11/03/2005US20050245467 Method of treating symptoms of common cold, allergic rhinitis and infections relating to the respiratory tract
11/03/2005US20050245464 Use of lipid conjugates in the treatment of diseases
11/03/2005US20050245458 Novel compounds as inhibitors of hepatitis C virus NS3 serine protease
11/03/2005US20050245457 Pseudopeptides growth hormone secretagogues
11/03/2005US20050245456 Combination therapy to prevent and treat diarrhea induced by cancer treatment
11/03/2005US20050245455 Gonadotropin releasing hormone antagonists in gel-forming concentrations
11/03/2005US20050245454 Methods and compositions for impairing multiplication of HIV-1
11/03/2005US20050245453 Peptides derived from cadherin and methods of use thereof
11/03/2005US20050245452 Pharmaceutical use of novispirins
11/03/2005US20050245451 Peptides selectively lethal to malignant and transformed mammalian cells
11/03/2005US20050245450 Method of screening a compound for anxiolytic activity in an apolipoprotein E knockout animal
11/03/2005US20050245449 Methods for modifying cell motility using factor VIIa antagonist
11/03/2005US20050245448 DTAT fusion toxin
11/03/2005US20050245447 Fusion polypeptide capable of binding vascular endothelial growth factor (VEGF), wherein polypeptide consists of immunoglobulin-like (Ig) domain 2 of a first VEGF receptor and Ig domain 3 of a second VEGF receptor and multimerizing component; use in decreasing or inhibiting plasma leakage; eye disorders
11/03/2005US20050245446 Materials for the delivery of biologically-active material to cells
11/03/2005US20050245445 Molecules that selectively home to vasculature of premalignant or malignant lesions of the pancreas and other organs
11/03/2005US20050245444 Method of using recombinant human antithrombin for neurocognitive disorders
11/03/2005US20050245443 Bacteria strain and bacteriocin produced therefrom
11/03/2005US20050245441 Use of compounds having gip activity for the treatment of disorders associated with abnormal loss of cells and/or for the treatment of obesity
11/03/2005US20050245440 Regulation of a novel colon specific retinol dehydrogenase by apc and cdx2
11/03/2005US20050245439 Prevention of joint destruction
11/03/2005US20050245438 For detecting, in the body of a human being, tumors having SSTR4 and their metastases in tissues, useful in drug-screening
11/03/2005US20050245437 Peptides having antimicrobial properties and compositions containing them, notably for the preservation of foodstuffs
11/03/2005US20050245436 Pheromones and the luteinizing hormone for inducing proliferation of neural stem cells and neurogenesis
11/03/2005US20050245435 Compounds for enzyme inhibition
11/03/2005US20050245434 Oxygenated dibenzo-alpha-pyrone chromoproteins
11/03/2005US20050245433 administering encapsulated cysteamine compound to treat hypercholesterolemia, non-insulin dependent diabetes; lowering uric acid levels
11/03/2005US20050244969 Transient immortalization
11/03/2005US20050244965 culturing with an effective amount of granulocyte-macrophage colony stimulating factor, using brain tissue cells; transplantation; treating multiple sclerosis demyelination
11/03/2005US20050244931 Therapeutic polypeptide with prolonged shelf-life and increased half life for use in treatment of cell proliferative, cardiovascular, inflammatory and autoimmune disorders
11/03/2005US20050244930 IL-21 antagonists
11/03/2005US20050244915 Assays for modulators of asparaginyl hydroxylase
11/03/2005US20050244905 Nitrated fibrinogen as a marker for coronary artery disease and rapid blood clot formation
11/03/2005US20050244896 Diagnostics and therapeutics for diseases associated with neuropeptide ff receptor 2 (npff2)
11/03/2005US20050244894 Modulators of paraptosis and related methods
11/03/2005US20050244889 For selectively inhibiting signal transduction pathways using an active fragment of a p/CIP polypeptide or a nucleic acid molecule encoding such active fragment of a p/CIP polypeptide or a nucleic acid molecule encoding such an acive fragment
11/03/2005US20050244888 Antibodies to human chemokine beta-9
11/03/2005US20050244877 Splice variants of CD40-receptor
11/03/2005US20050244876 Human tumor necrosis factor receptors TR13 and TR14
11/03/2005US20050244862 Identification of ligands by selective amplification of cells transfected with receptors
11/03/2005US20050244859 Cell based assay
11/03/2005US20050244855 Novel human kinase proteins and polynucleotides encoding the same
11/03/2005US20050244849 Screening assays for rheumatoid arthritis
11/03/2005US20050244844 serine/threonine phosphatases (PP1); immobilization, screening
11/03/2005US20050244833 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
11/03/2005US20050244826 Compositions for diagnosis and therapy of diseases associated with aberrant expression of kremen and/or wnt
11/03/2005US20050244823 Novel epitopes for celiac disease and autoimmune diseases, methods for detecting those and novel non-antigenic food compounds
11/03/2005US20050244817 Mammalian genes involved in viral infection and tumor suppression
11/03/2005US20050244806 Mutant proteins and use thereof for the manufacture of medicaments and the treatment of humans or animals suffering from conformational diseases
11/03/2005US20050244512 Ophthalmic fluid and method of delivering same
11/03/2005US20050244503 Small-particle pharmaceutical formulations of antiseizure and antidementia agents and immunosuppressive agents
11/03/2005US20050244456 Surface coating comprising bioactive compound
11/03/2005US20050244451 Method and device for reducing susceptibility to fractures in vertebral bodies
11/03/2005US20050244435 Comprises clostridial neurotoxin light chain domains; endopeptidases; vaccines; fusion proteins; for inhibiting exocytosis
11/03/2005US20050244434 Tat-based tolerogen compositions and methods of making and using same
11/03/2005US20050244433 Administering vaccine comprising human papillomavirus L1 protein and excludes E protein to induce immune response
11/03/2005US20050244430 Orthopoxvirus vectors, genes and products thereof
11/03/2005US20050244425 Histidine-tagged intimin and methods of using intimin to stimulate an immune response and as an antigen carrier with targeting capability
11/03/2005US20050244424 Carbohydrate-based synthetic vaccines for hiv
11/03/2005US20050244423 administering to mammals genetic engineered or pegylated polypeptides, to reduce liver inflammation associated with viral infections
11/03/2005US20050244421 Compositions and methods for modulating immune response
11/03/2005US20050244418 Recombinant tumor specific antibody and use thereof
11/03/2005US20050244417 Using mixture comprising human estrogen specific immunoglobulin and tumor necrosis factor related apoptosis inducing ligand (APO-2L) for use as tool to enhance apoptosis in cancer cells
11/03/2005US20050244414 Method to ameliorate osteolysis and metastasis
11/03/2005US20050244412 Method and composition for regulating activity of regulatory T cells
11/03/2005US20050244411 BAFF, inhibitors thereof and their use in the modulation of B-cell response and treatment of autoimmune disorders
11/03/2005US20050244406 Monoclonal antibodies against extracellular loops of c5ar
11/03/2005US20050244405 Antagonist for endothelial growth agents for treatment of edema and for kidney dialysis
11/03/2005US20050244401 Compositions and methods for reducing lung volume
11/03/2005US20050244400 Acid alpha-glucosidase and fragments thereof
11/03/2005US20050244399 Materials and method for promotion of nerve regeneration
11/03/2005US20050244398 Pharmaceutical preparation and method of treatment of human malignancies with arginine deprivation
11/03/2005US20050244397 Process for prolonging the after-harvest life of citrus fruit
11/03/2005US20050244396 Application of a non-toxic organic enzyme formulation and process for reducing fungi-caused decay on fruits and vegetables
11/03/2005US20050244395 Targeted enzyme prodrug therapy
11/03/2005US20050244393 Sealant or tissue generating product
11/03/2005US20050244386 Method of transplanting in a mammal and treating diabetes mellitus by administering a pseudo-islet like aggregate differentiated from a nestin-positive pancreatic stem cell
11/03/2005US20050244381 Adenovirus including a gene coding for a superoxide dismutase
11/03/2005US20050244378 Method for treating glaucoma
1 ... 1354 1355 1356 1357 1358 1359 1360 1361 1362 1363 1364 1365 1366 1367 1368 1369 1370 1371 1372 1373 1374 ... 3163